Bionest

“Beyond the Pill” – Part Three: Patient-centricity Creates New Business Opportunities Outside Pharma, Too

Factors are converging that make patient-centric initiatives a key business opportunity, not just for pharmaceutical and biotechnology companies with treatments to develop and market, but increasingly also for those outside of the traditional health care industry.   One of the most important is the rise of technologies for capturing, aggregating and creating value from “big...

Bionest

“Beyond the Pill” — Part Two: Value-Added Services Offer Benefit to Multiple Audiences

In our first “Beyond the Pill” post, we discussed the increasing move towards patient-centric programs that go past an actual prescription to help build relationships with patients and physicians and facilitate the provision of a number of related services to improve compliance and treatment outcomes and keep patients on drug long-term. The benefit of such...